奥利万星

Oritavancin

Abstract

No information is available on the use of oritavancin during breastfeeding. Oritavancin is poorly absorbed orally, so it is not likely to reach the bloodstream of the infant or cause any adverse effects in breastfed infants. Monitor the infant for possible effects on the gastrointestinal tract, such as diarrhea, vomiting, and candidiasis (e.g., thrush, diaper rash). However, because there is no published experience with oritavancin during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.

摘要

关于哺乳期使用奥利万星的信息尚无可用资料。奥利万星口服吸收差，因此不太可能进入婴儿的血液循环或对母乳喂养的婴儿造成任何不良影响。监测婴儿是否有胃肠道方面的可能影响，如腹泻、呕吐和念珠菌病（如鹅口疮、尿布疹）。然而，由于哺乳期使用奥利万星尚无公开经验，可能首选替代药物，尤其是在哺育新生儿或早产儿期间。